Download | < Back |
09 Feb 2022 | |
In pursuance of the LODR with Stock Exchange, please find enclosed the Unaudited quarterly financial results for the quarter ended December 2021 approved by the Board of the Company in its Meeting on 08.02.2022. The XBRL filing will be made succeeding to this. | |
View all announcements for BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD. | Source: BSE India |